BALTIMORE--(BUSINESS WIRE)--BioMarker Strategies, a Baltimore-based cancer diagnostics and medical device company, has named Kären Olson as its new Chief Executive Officer. Olson is the former president and CEO of Adhesives Research, a $115 million multinational specialty chemical and drug delivery company which was the first company to successfully develop medicated dissolvable thin strips.
